Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

NCT00895895 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

526

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Alzheimer Disease

Interventions

DRUG: Placebo
DRUG: SAM-531 1.5 mg
DRUG: SAM-531 3.0 mg
DRUG: SAM-531 5.0 mg
DRUG: Donepezil

Sponsor

Pfizer